IS7181A - Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau - Google Patents

Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau

Info

Publication number: IS7181A
Authority: IS; Iceland
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; tetrahydro; aralkyl
Prior art date: 2001-10-18

Application number

IS7181A

Other languages

English (en)

Other versions

IS2486B (is

Inventor

Baroni Marco

Bourrie Bernard

Cardamone Rosanna

Casellas Pierre

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-18

Filing date

2004-03-11

Publication date

2004-03-11

2004-03-11 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2004-03-11 Publication of IS7181A publication Critical patent/IS7181A/is

2008-12-15 Publication of IS2486B publication Critical patent/IS2486B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

IS7181A 2001-10-18 2004-03-11 Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau IS2486B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0113469A FR2831166B1 (fr)	2001-10-18	2001-10-18	Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
PCT/FR2002/003508 WO2003033466A1 (fr)	2001-10-18	2002-10-14	Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number	Publication Date
IS7181A true IS7181A (is)	2004-03-11
IS2486B IS2486B (is)	2008-12-15

Family

ID=8868455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7181A IS2486B (is)	2001-10-18	2004-03-11	Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau

Country Status (21)

Country	Link
US (2)	US7326723B2 (is)
EP (1)	EP1438291B1 (is)
JP (2)	JP4524107B2 (is)
KR (1)	KR100935787B1 (is)
CN (2)	CN100335464C (is)
AT (1)	ATE303991T1 (is)
AU (1)	AU2002360117B2 (is)
BR (1)	BR0213359A (is)
CA (1)	CA2460822C (is)
DE (1)	DE60206068T2 (is)
EA (1)	EA007324B1 (is)
FR (1)	FR2831166B1 (is)
HU (1)	HUP0401713A3 (is)
IL (2)	IL160820A0 (is)
IS (1)	IS2486B (is)
MX (1)	MXPA04003568A (is)
NO (1)	NO326490B1 (is)
NZ (1)	NZ531846A (is)
PL (1)	PL368802A1 (is)
WO (1)	WO2003033466A1 (is)
ZA (1)	ZA200402059B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA007657B1 (ru)	2001-10-15	2006-12-29	Янссен Фармацевтика Н.В.	Замещенные производные 4-фенил-4-[1н-имидазол-2-ил] пиперидина для снижения ишемического повреждения
MY140489A (en)	2003-12-26	2009-12-31	Eisai R&D Man Co Ltd	1,2-di (cyclic) substituted benzene compounds
US7410971B2 (en)	2003-12-26	2008-08-12	Eisai R&D Management Co., Ltd.	1,2-di(cyclic)substituted benzene compounds
US20060276465A1 (en) *	2003-12-26	2006-12-07	Eisai R&D Management Co., Ltd.	1,2-di(cyclic) substituted benzene compounds
CN100526301C (zh) *	2003-12-26	2009-08-12	卫材R&D管理有限公司	1,2-二(环式基)取代苯化合物
AU2005320217B2 (en)	2004-12-20	2011-11-10	Eisai R & D Management Co., Ltd.	Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
MY144974A (en) *	2005-06-14	2011-11-30	Eisai R&D Man Co Ltd	1,2-di(cyclic) substituted benzene derivatives
US9493383B2 (en)	2005-09-15	2016-11-15	Lg Chem, Ltd.	Organic compound and organic light emitting device using the same
US9608205B2 (en)	2005-09-15	2017-03-28	Lg Chem, Ltd.	Organic compound and organic light emitting device using the same
US8298683B2 (en) *	2005-09-15	2012-10-30	Lg Chem, Ltd.	Organic compound and organic light emitting device using the same
US9631169B2 (en) *	2008-06-05	2017-04-25	Invivo Sciences Inc.	Three dimensional tissues for high-throughput assays

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3804878A (en) *	1969-09-08	1974-04-16	Ciba Geigy Corp	Hydrogenated araliphatic acids
ES2068497T3 (es) *	1990-03-12	1995-04-16	Yamanouchi Pharma Co Ltd	Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
FR2662442A1 (fr) *	1990-05-23	1991-11-29	Midy Spa	Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
DE69520360T2 (de) *	1994-07-04	2001-08-09	Takeda Chemical Industries, Ltd.	Phosphonsäure verbindungen imre herstellung und verwendung
FR2734819B1 (fr) *	1995-05-31	1997-07-04	Adir	Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2762514B1 (fr) *	1997-04-29	1999-10-22	Sanofi Sa	Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) *	1997-05-28	2003-06-06	Sanofi Sa	Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US6070784A (en) *	1998-07-08	2000-06-06	The Boeing Company	Contact backup roller approach to FSW process
CA2386417C (en) *	1999-10-22	2010-09-28	Sanofi-Synthelabo	Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
KR100792186B1 (ko) *	1999-12-30	2008-01-08	하. 룬트벡 아크티에 셀스카브	4-페닐-1-피페라지닐, -피페리디닐 및 -테트라히드로피리딜유도체
FR2803593B1 (fr) *	2000-01-06	2002-02-15	Sanofi Synthelabo	Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2002085888A1 (fr) *	2001-04-20	2002-10-31	Sanofi-Synthelabo	Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenants
FR2823749B1 (fr) *	2001-04-20	2004-02-20	Sanofi Synthelabo	Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant
JP3687912B2 (ja) *	2002-08-29	2005-08-24	東芝テック株式会社	プリンタユニット

2001
- 2001-10-18 FR FR0113469A patent/FR2831166B1/fr not_active Expired - Fee Related
2002
- 2002-10-14 EA EA200400323A patent/EA007324B1/ru not_active IP Right Cessation
- 2002-10-14 CN CNB028207548A patent/CN100335464C/zh not_active Expired - Fee Related
- 2002-10-14 HU HU0401713A patent/HUP0401713A3/hu unknown
- 2002-10-14 DE DE60206068T patent/DE60206068T2/de not_active Expired - Lifetime
- 2002-10-14 US US10/492,770 patent/US7326723B2/en not_active Expired - Fee Related
- 2002-10-14 CA CA2460822A patent/CA2460822C/en not_active Expired - Fee Related
- 2002-10-14 KR KR1020047005587A patent/KR100935787B1/ko not_active Expired - Fee Related
- 2002-10-14 AT AT02795311T patent/ATE303991T1/de not_active IP Right Cessation
- 2002-10-14 IL IL16082002A patent/IL160820A0/xx unknown
- 2002-10-14 WO PCT/FR2002/003508 patent/WO2003033466A1/fr not_active Ceased
- 2002-10-14 JP JP2003536206A patent/JP4524107B2/ja not_active Expired - Fee Related
- 2002-10-14 EP EP02795311A patent/EP1438291B1/fr not_active Expired - Lifetime
- 2002-10-14 AU AU2002360117A patent/AU2002360117B2/en not_active Ceased
- 2002-10-14 BR BR0213359-8A patent/BR0213359A/pt not_active Application Discontinuation
- 2002-10-14 NZ NZ531846A patent/NZ531846A/en not_active IP Right Cessation
- 2002-10-14 MX MXPA04003568A patent/MXPA04003568A/es active IP Right Grant
- 2002-10-14 CN CNA2007101368627A patent/CN101096337A/zh active Pending
- 2002-10-14 PL PL02368802A patent/PL368802A1/xx not_active IP Right Cessation
2004
- 2004-03-10 IL IL160820A patent/IL160820A/en not_active IP Right Cessation
- 2004-03-11 IS IS7181A patent/IS2486B/is unknown
- 2004-03-15 ZA ZA200402059A patent/ZA200402059B/en unknown
- 2004-04-16 NO NO20041573A patent/NO326490B1/no not_active IP Right Cessation
2007
- 2007-12-18 US US11/958,476 patent/US7858824B2/en not_active Expired - Fee Related
2010
- 2010-02-18 JP JP2010033642A patent/JP2010120961A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
BR0213359A (pt)	2004-10-26
CN101096337A (zh)	2008-01-02
HUP0401713A2 (hu)	2004-12-28
NO326490B1 (no)	2008-12-15
PL368802A1 (en)	2005-04-04
ZA200402059B (en)	2005-03-15
WO2003033466A1 (fr)	2003-04-24
FR2831166A1 (fr)	2003-04-25
KR100935787B1 (ko)	2010-01-06
NO20041573L (no)	2004-07-07
KR20050036866A (ko)	2005-04-20
NZ531846A (en)	2005-10-28
HUP0401713A3 (en)	2012-08-28
FR2831166B1 (fr)	2004-02-27
HK1065543A1 (en)	2005-02-25
EP1438291A1 (fr)	2004-07-21
DE60206068T2 (de)	2006-07-13
DE60206068D1 (de)	2005-10-13
EP1438291B1 (fr)	2005-09-07
ATE303991T1 (de)	2005-09-15
JP4524107B2 (ja)	2010-08-11
JP2005505621A (ja)	2005-02-24
MXPA04003568A (es)	2004-07-30
EA200400323A1 (ru)	2004-10-28
US20050014795A1 (en)	2005-01-20
CN1571770A (zh)	2005-01-26
US20080097117A1 (en)	2008-04-24
IS2486B (is)	2008-12-15
IL160820A (en)	2009-06-15
US7858824B2 (en)	2010-12-28
CA2460822A1 (en)	2003-04-24
CN100335464C (zh)	2007-09-05
CA2460822C (en)	2011-01-04
AU2002360117B2 (en)	2008-07-17
JP2010120961A (ja)	2010-06-03
EA007324B1 (ru)	2006-08-25
IL160820A0 (en)	2004-08-31
US7326723B2 (en)	2008-02-05

Publication	Publication Date	Title
MXPA02012033A (es)	2003-04-25	Derivados de 2-aminocarbonil-9h-purina.
GEP20074133B (en)	2007-06-25	New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
EA200200940A1 (ru)	2003-02-27	Производные азетидина, способ их получения и содержащие их фармацевтические композиции
EA200100972A1 (ru)	2002-02-28	Новые соединения и композиции как ингибиторы протеаз
IL143545A (en)	2005-08-31	Thrombin inhibitors and pharmaceutical compositions containing them
YU89402A (sh)	2005-11-28	5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze
IS7181A (is)	2004-03-11	Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau
UA83648C2 (ru)	2008-08-11	Антагонисты аденозиндифосфатного рецептора тромбоцитов
IL143625A0 (en)	2002-04-21	Sulfonamide hydroxamates
EA200301203A1 (ru)	2004-04-29	Новые соединения и композиции как ингибиторы катепсина
ATE453389T1 (de)	2010-01-15	Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
BR0318521A (pt)	2006-09-12	arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
YU76500A (sh)	2003-02-28	Hemijska sinzeza morfolinskih derivata
TR200503401T1 (tr)	2008-03-21	Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
WO2003080631A8 (en)	2004-06-10	Plasma carboxypeptidase b inhibitors
DE60227421D1 (de)	2008-08-14	Rmazeutische zusammensetzung und verwendung davon
PL362126A1 (en)	2004-10-18	New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
EA200300400A1 (ru)	2003-10-30	17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
MY136065A (en)	2008-08-29	Prodrugs to nmda receptor ligands
DK1250335T3 (da)	2005-11-14	Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
HUP0401895A2 (hu)	2004-12-28	Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
IL154915A0 (en)	2003-10-31	Method for producing chiral compounds
MXPA04002784A (es)	2004-07-29	Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
GB9924759D0 (en)	1999-12-22	Process for preparing peptide intermediates
YU82302A (sh)	2005-11-28	Derivati 2-aminokarbonil-9h-purina